Zaire strain

The trial, to be conducted by the University of Oxford, will involve 50 healthy volunteers in the age group of 18 to 55 years Pune: The Serum Institute of India (SII) has dispatched 4,000 investigational doses of a newly manufactured Ebola vaccine targeting the Bundibugyo strain, thus paving the way for phase I human trials…